ARRAY BIOPHARMA INC 4/A SEC Filings

Filed On	Filing
17 Aug 2018	Form 4/A: Lefkoff Kyle, Director Gave 2,085 shares as a gift
06 Apr 2017	Form 4/A: Squarer Ron, Director Gave up 17,563 shares to cover exercise price or tax ($157K)
06 Apr 2017	Form 4/A: Sandor Victor, Chief Medical Officer Gave up 7,303 shares to cover exercise price or tax ($65.3K)
06 Apr 2017	Form 4/A: Saccomano Nicholas A, CSO Gave up 6,543 shares to cover exercise price or tax ($58.5K)
06 Apr 2017	Form 4/A: Robbins Andrew R, COO Gave up 9,167 shares to cover exercise price or tax ($82K)
06 Apr 2017	Form 4/A: Moore John R, VP, General Counsel Gave up 6,370 shares to cover exercise price or tax ($56.9K)
11 Jan 2016	Form 4/A: Redmile Group, Llc, 10% owner and 1 other Bought 317,548 shares ($1.45M) · Bought 182,452 shares ($852K) · Bought 100,140 shares ($451K)
24 Mar 2015	Form 4/A: Moore John R, VP, General Counsel Holds 15,384 shares of Common Stock
24 Mar 2015	Form 4/A: Squarer Ron, Director Exercised 77,881 Restricted Stock Units
31 Oct 2014	Form 4/A: Baum Charles M, Director Granted 25,000 Stock Option (Right to Buy)
07 Aug 2014	Form 4/A: Array Biopharma Inc, 10% owner · Loxo Oncology, Inc. Received 1,609,560 shares by conversion
02 Aug 2013	Form 4/A: Koch Kevin, President, CSO Gave up 10,323 shares to cover exercise price or tax ($62.7K)
22 Jun 2005	Form 4/A: Carruthers Michael, CHIEF FINANCIAL OFFICER Sold 5,000 shares ($30.8K) · Received 5,000 shares by exercise or conversion ($1.18K)
14 May 2003	Form 4/A: Koch Kevin, Director

Comments